{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T11:37:48Z","timestamp":1795261068625,"version":"4.10.3"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study aimed to investigate the relationship between the timing of anticoagulation initiation and clinical outcomes in critically ill patients with sepsis-induced coagulopathy (SIC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using the MIMIC-IV database. Adult patients diagnosed with SIC (ISTH-SIC score \u2265 4) and receiving anticoagulation therapy during their ICU stay were included. Anticoagulation therapy was defined as administration of unfractionated heparin, low-molecular-weight heparin, vitamin K antagonists, or direct oral anticoagulants, as captured in medication records; additionally, a heparin-only analysis was performed given its predominant use in this population. Patients were stratified into early (\u2264 48\u00a0hours post-ICU admission) or delayed (&gt; 48\u00a0hours) anticoagulation groups. Baseline characteristics were balanced using propensity score matching (PSM). Primary outcomes included 28-day, 60-day, and 90-day mortality. Cox proportional hazard models were applied to assess survival differences across subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 12\u00a0738 eligible patients, 10\u00a0689 received early anticoagulation and 2049 received delayed treatment. After PSM (n\u00a0=\u00a03986), delayed anticoagulation was associated with significantly lower 28-day mortality (15% vs 19%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and similar reductions were observed at 60 and 90\u00a0days. Kaplan-Meier survival curves showed significantly better survival in the delayed group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Subgroup analyses revealed that the survival benefit was more pronounced in patients aged &gt;65\u00a0years, those without acute kidney injury (AKI), platelet count \u2265 100\u00a0\u00d7\u00a010\n                      <jats:sup>9<\/jats:sup>\n                      \/L, Sequential Organ Failure Assessment score \u2265 6, and those treated with unfractionated heparin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Among critically ill patients with SIC, delayed initiation of anticoagulation was independently associated with improved short- and medium-term survival. These findings support a phenotype-guided, time-stratified approach to anticoagulation in sepsis and highlight the need for prospective trials to validate optimal timing strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004773","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:01:10Z","timestamp":1770130870000},"page":"10117-10128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Delayed anticoagulation is associated with lower mortality in sepsis-induced coagulopathy: a large-scale, propensity-score-matched cohort study from MIMIC-IV"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-8670","authenticated-orcid":false,"given":"Tiantian","family":"Zhou","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Qin","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Ni","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Huang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-2659","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"R1-20260424","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12185-021-03152-4","article-title":"Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan","volume":"114","author":"Tanaka","year":"2021","journal-title":"Int J Hematol"},{"key":"R2-20260424","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13613-022-01093-7","article-title":"The prevalence of sepsis-induced coagulopathy in patients with sepsis \u2013 a secondary analysis of two German multicenter randomized controlled trials","volume":"13","author":"Schmoch","year":"2023","journal-title":"Ann Intens Care"},{"key":"R3-20260424","article-title":"External validation of the two newly proposed criteria for assessing coagulopathy in Sepsis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb Haemost"},{"key":"R4-20260424","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2147\/JIR.S504184","article-title":"The mechanisms of sepsis induced coagulation dysfunction and its treatment","volume":"18","author":"Zhu","year":"2025","journal-title":"J Inflamm Res"},{"key":"R5-20260424","doi-asserted-by":"crossref","first-page":"1144229","DOI":"10.3389\/fimmu.2023.1144229","article-title":"Endothelial dysfunction and immunothrombosis in sepsis","volume":"14","author":"Maneta","year":"2023","journal-title":"Front Immunol"},{"key":"R6-20260424","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1213\/ANE.0000000000006888","article-title":"Sepsis-induced coagulopathy: a comprehensive narrative review of pathophysiology, clinical presentation, diagnosis, and management strategies","volume":"138","author":"Williams","year":"2024","journal-title":"Anesthesia Analg"},{"key":"R7-20260424","first-page":"10","article-title":"Early prophylactic anticoagulation with heparin alleviates mortality in critically ill patients with sepsis: a retrospective analysis from the MIMIC-IV database","author":"Zou","year":"2022","journal-title":"Burns Trauma"},{"key":"R8-20260424","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R9-20260424","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13054-021-03541-5","article-title":"Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies","volume":"25","author":"Kudo","year":"2021","journal-title":"Critical Care"},{"key":"R10-20260424","doi-asserted-by":"crossref","first-page":"e017046","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"R11-20260424","first-page":"145\u201353","article-title":"Communication from the scientific and standardization committee of the international society on thrombosis and haemostasis on sepsis-induced coagulopathy in the management of sepsis","volume":"21","author":"Iba","year":"2023","journal-title":"J Thromb Haemost"},{"key":"R12-20260424","first-page":"1989\u201394","article-title":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R13-20260424","doi-asserted-by":"crossref","first-page":"34\u201345","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R14-20260424","article-title":"The coagulation system and its function in early immune defense","volume":"112","author":"Van der Poll","year":"2014","journal-title":"Thromb Haemost"},{"key":"R15-20260424","doi-asserted-by":"crossref","first-page":"455\u201357","DOI":"10.1007\/s00134-016-4607-x","article-title":"Should all septic patients be given systemic anticoagulation? No","volume":"43","author":"Van der Poll","year":"2017","journal-title":"Intensive Care Med"},{"key":"R16-20260424","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Scientific Data"},{"key":"R17-20260424","doi-asserted-by":"crossref","first-page":"801\u201310","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"R18-20260424","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of Artificial Intelligence","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R19-20260424","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2023.05.028","article-title":"Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation","volume":"21","author":"Iba","year":"2023","journal-title":"J Thromb Haemost"},{"key":"R20-20260424","first-page":"89\u201395","article-title":"Sepsis-induced coagulopathy and disseminated intravascular coagulation","volume":"46","author":"Iba","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"R21-20260424","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k4891","article-title":"Sepsis associated acute kidney injury","author":"Poston","year":"2019","journal-title":"BMJ (Clinical Research Ed)"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000004773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:12Z","timestamp":1786038492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000004773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004773","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"2025-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}